Fingerprint
Dive into the research topics of 'Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Hans Christoph Diener, Ronald E. DeGryse, Richard B. Lipton, Catherine C. Turkel
Research output: Contribution to journal › Article › peer-review
98
Scopus
citations